Interim analysis of a phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with metastatic breast cancer

被引：4
|
作者：
Forero, A.
Burris, H., III
Mita, M.
Specht, J.
Weise, A.
Liu, M. C.
Modi, S.
Pusztai, L.
Kostic, A.
Yang, J.
Li, M.
Hengel, S.
Miller, K.
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA
[3] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[4] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA
[5] Karmanos Canc Inst, Detroit, MI USA
[6] Mayo Clin, Rochester, MN USA
[7] Mem Sloan Kettering Canc Ctr, New York, NY USA
[8] Yale Univ, Sch Med, New Haven, CT USA
[9] Seattle Genet Inc, Bothell, WA USA
[10] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P3-14-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-14-05
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase 1 study of the antibody-drug conjugate (ADC) SGN-LIV1A in patients with heavily pretreated metastatic breast cancer
    Forero-Torres, A.
    Modi, S.
    Specht, J.
    Miller, K.
    Weise, A.
    Burris, H., III
    Liu, M.
    Krop, I.
    Pusztai, L.
    Kostic, A.
    Li, M.
    Mita, M.
    CANCER RESEARCH, 2017, 77
  • [2] SGN-LIV1A: A Novel Antibody-Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer
    Sussman, Django
    Smith, Leia M.
    Anderson, Martha E.
    Duniho, Steve
    Hunter, Joshua H.
    Kostner, Heather
    Miyamoto, Jamie B.
    Nesterova, Albina
    Westendorf, Lori
    Van Epps, Heather A.
    Whiting, Nancy
    Benjamin, Dennis R.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (12) : 2991 - 3000
  • [3] Phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with heavily pretreated triple-negative metastatic breast cancer
    Modi, Shanu
    Pusztai, Lajos
    Forero, Andres
    Mita, Monica
    Miller, Kathy D.
    Weise, Amy
    Krop, Ian
    Burris, Howard, III
    Kalinsky, Kevin
    Tsai, Michaela
    Liu, Minetta C.
    Hurvitz, Sara A.
    Wilks, Sharon
    Ademuyiwa, Foluso
    Diab, Sami
    Han, Hyo S.
    Kato, Giraldo
    Nanda, Rita
    O'Shaughnessy, Joyce
    Kostic, Ana
    Li, Martha
    Specht, Jennifer
    CANCER RESEARCH, 2018, 78 (04)
  • [4] SGN-LIV1A, an antibody-drug conjugate (ADC), in patients with LIV-1-positive breast cancer.
    Kostic, Ana
    Anderson, Martha
    Duniho, Steven
    Miyamoto, Jamie
    Nesterova, Albina
    Sussman, Django
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] SGN-LIV1A: A phase 1 trial evaluating a novel antibody-drug conjugate in patients with LIV-1-positive breast cancer
    Forero, Andres
    Burris, Howard, III
    LoRusso, Patricia
    Specht, Jennifer
    Miller, Kathy
    Mita, Monica
    Liu, Minetta C.
    Modi, Shanu
    Pusztai, Lajos
    Sussman, Django
    Kostic, Ana
    CANCER RESEARCH, 2015, 75
  • [6] SGN-LIV1A: a development stage antibody drug-conjugate targeting LIV-1 for the treatment of metastatic breast cancer.
    Sussman, Django
    Smith, Leia M.
    Anderson, Martha E.
    Duniho, Steve
    Hunter, Joshua H.
    Kostner, Heather
    Miyamoto, Jamie B.
    Nesterova, Albina
    Westendorf, Lori
    Van Epps, Heather A.
    Whiting, Nancy
    Benjamin, Dennis R.
    CANCER RESEARCH, 2013, 73 (08)
  • [7] Preclinical combinations of the antibody-drug conjugate SGN-LIV1A with chemotherapies show increased activity
    Li, Fu
    Anderson, Martha
    Hunter, Joshua
    Miyamoto, Jaime
    Ulrich, Michelle
    Kostic, Ana
    Law, Che-Leung
    Sussman, Django
    CANCER RESEARCH, 2016, 76
  • [8] LIV-1 Antibody-Drug Conjugate: A Novel Therapeutic Agent for Breast Cancer
    Smith, L. M.
    Sussman, D.
    Nesterova, A.
    Westendorf, L.
    Duniho, S.
    Anderson, M.
    Mbow, B.
    Gregoire, A.
    Hunter, J.
    Whiting, N.
    Law, C. L.
    Benjamin, D. R.
    CANCER RESEARCH, 2010, 70
  • [9] LIV-1 antibody-drug conjugate: A novel therapeutic agent for breast and prostate cancer
    Sussman, Django
    Nesterova, Albina
    Westendorf, Lori
    Duniho, Steven
    Anderson, Martha
    Mbow, Brianna
    Gregoire, Ashley
    Hunter, Joshua H.
    Whiting, Nancy
    Corey, Eva
    Vessella, Robert L.
    Benjamin, Dennis R.
    Smith, Leia M.
    CANCER RESEARCH, 2011, 71
  • [10] SGNLVA-001: A phase 1 open-label dose escalation and expansion study of SGN-LIV1A administered weekly in breast cancer
    Beckwith, Heather C.
    Medgyesy, Diana C.
    Abraham, Jame
    Nanda, Rita
    Tkaczuk, Katherine H. R.
    Krop, Ian E.
    Pusztai, Lajos
    Modi, Shanu
    Mita, Monica M.
    Specht, Jennifer M.
    Hurvitz, Sara A.
    Han, Hyo S.
    Kalinsky, Kevin
    Wilks, Sharon
    O'Shaughnessy, Joyce
    Hart, Lowell L.
    Rugo, Hope S.
    Mitri, Zahi I.
    Garfin, Phillip M.
    Burris, Howard A., III
    CANCER RESEARCH, 2021, 81 (04)
12345